“…Effective antibacterial action also requires high doses of these nanomaterials. Many studies indicate that the lowest concentration of ZnO nanoparticle suspension, which caused an over 99.9% reduction in initial inoculum (MBC) ranges from tens to even 5000 mg/L depending on the bacterial serotype and the method of nanoparticle synthesis (Alekish, Ismail, Albiss, & Nawasrah, 2018; Hoseinzadeh, Alikhani, Samarghandi, & Shirzad‐Siboni, 2013; Raj, Lawrence, Jalees, & Lawrence, 2015; Souza, Haberbeck, Riella, Ribeiro, & Carciofi, 2019). Despite high contact concentrations, the concentration of ZnO‐NPs in the body will be lower, and therefore, the amounts used for the presented research were much lower than usually used in industry.…”